BioSpace News Archive

MiMedx Group, Inc.today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Robert B. Stein, M.D., Ph.D., Executive Vice President, Research and Development, will present at the Raymond James 2021 Human Health Innovation Conference on Wednesday, June 23, 2021.

VistaGen Therapeutics, Inc today announced the Company will be added to the Russell 2000® Index at the conclusion of the 2021 Russell Indexes annual reconstitution, effective June 28, 2021.

Braxia Scientific Corp. is pleased to announce its participation at the upcoming Psychedelics in Psychiatry and Beyond Virtual Conference.

Ironwood Pharmaceuticals, Inc. today announced that The American Journal of Gastroenterology published full results from the company’s Phase IIIb clinical trial evaluating LINZESS®

Teva Pharmaceuticals today announced the U.S. launch of its generic version of once daily SOOLANTRA® (ivermectin) Cream, 1% for the treatment of inflammatory lesions of rosacea.

Selecta Biosciences, Inc. (NASDAQ: SELB), today announced that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will provide a corporate update and participate in one-on-one investor meetings at the Raymond James Human Health Innovation Conference

Can-Fite BioPharma Ltd . today announced the Chinese National Intellectual Property Administration has issued a Notice of Allowance for its pate titled “An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation”.

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced it will host a virtual R&D Day at 10:00 a.m. – 12:00 p.m. ET on Wednesday, June 23, 2021.

The National Cancer Center is pleased to announce the recipients of its 2021-22 research grant awards, which support research fellows pursuing promising and innovative cancer research.

Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Wednesday, July 28, 2021